Source: International Congress 2014 – Markers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Vanfleteren, M. Spruit, M. Groenen, E. Rutten, P. Bruijnzeel, E. Wouters, F. Franssen (Horn, Maastricht, Netherlands; Mölndal, Sweden). A multimarker approach to identify atherosclerosis in COPD. Eur Respir J 2014; 44: Suppl. 58, 567

Member's Comments

No comment yet.

Related content which might interest you: The role of COPD in development of osteoporosis Source: International Congress 2014 – Markers Year: 2014 The distribution of phenotypes in a population of severe COPD Source: International Congress 2014 – COPD exacerbations Year: 2014 COPD and depression: Prevalence and interaction Source: International Congress 2014 – Comorbidities Year: 2014 Biomarkers in COPD exacerbation, the role of adiponectin Source: International Congress 2014 – Predictors Year: 2014 Adrenomedullin optimizes mortality prediction in COPD Source: International Congress 2014 – COPD exacerbations Year: 2014 Features of systemic inflammation in patients with stable COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014 Gender differences in COPD patients Source: International Congress 2014 – Clinical presentations Year: 2014 Metabolic syndrome in patients with COPD Source: International Congress 2014 – Clinical presentations Year: 2014 What is the best biomarker of COPD stability? Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Mortality predictors in stable COPD Source: International Congress 2014 – Predictors Year: 2014 Comorbidity at COPD - is actual problem of pulmonology Source: International Congress 2014 – Predictors Year: 2014 Clustering asthma and COPD provides new evidence for both “British” and “Dutch” hypotheses of COPD development Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 Stable state MR-proadrenomedullin level in COPD patients; a validation study Source: International Congress 2014 – Comorbidities Year: 2014 Impact of comorbidities in COPD prognosys scores Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Metabolomic signature in COPD. Plasma and lung tissue comparison identify sphingolipids as potential biomakers Source: International Congress 2014 – Markers Year: 2014 Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort Source: International Congress 2014 – Clinical presentations Year: 2014 Role of inflammatory biomarkers in COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 GOLD and phenotypes: The new Czech COPD guidelines Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 COPDCoRi, an algorithm for predicting the risk of coronaropathy in COPD patients Source: International Congress 2014 – Prevalence of COPD and mortality from COPD Year: 2014 Clinical and inflammatory characteristics of 'unreported' COPD exacerbations Source: Annual Congress 2013 –COPD mechanisms Year: 2013